Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Denoising of ultra-low-dose <sup>15</sup>O positron emission tomography images using deep image prior with anatomical information extracted through magnetic resonance segmentation.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Fibronectin 1 (<i>FN1</i>)-rearranged Mesenchymal Neoplasms: An Updated Review.

Cancer genomics & proteomics·2026
Same author

Chondromyxoid Fibroma: An Updated Review.

In vivo (Athens, Greece)·2026
Same author

Acral Angioleiomyoma With Tumoral Calcinosis: A Rare Case Report and Literature Review.

In vivo (Athens, Greece)·2026
Same author

Calcifying Aponeurotic Fibroma: A Review and Update.

In vivo (Athens, Greece)·2026
Same author

Multinodular/Plexiform Schwannoma of the Ankle: A Case Report and Literature Review.

Cancer diagnosis & prognosis·2025

Related Experiment Video

Updated: Jul 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K

Histiocytic Sarcoma: A Review and Update.

Yuki Shinohara1, Shizuhide Nakayama2, Mikiko Aoki3

  • 1Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan.

International Journal of Molecular Sciences
|September 13, 2025
PubMed
Summary

Histiocytic sarcoma (HS) is a rare, aggressive cancer. This review covers its features, diagnosis using immunohistochemistry, genetic mutations, and limited treatment options, highlighting PD-L1 as a potential target.

Keywords:
diagnosishematopoietic neoplasmhistiocytic sarcomamalignant histiocytosispathogenesistreatment

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K

Related Experiment Videos

Last Updated: Jul 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.4K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.8K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Histiocytic sarcoma (HS) is an ultra-rare hematopoietic neoplasm.
  • It commonly presents in extranodal sites in adults and exhibits aggressive clinical behavior.
  • HS has a poor prognosis, with a median overall survival of approximately six months.

Purpose of the Study:

  • To provide a comprehensive overview of histiocytic sarcoma.
  • To discuss current knowledge on clinicoradiological features, histopathology, pathogenesis, and management.
  • To highlight recent findings and potential therapeutic targets.

Main Methods:

  • Review of current literature on histiocytic sarcoma.
  • Analysis of diagnostic criteria, including histopathology and immunohistochemistry.
  • Summary of identified genomic alterations and signaling pathway involvement.

Main Results:

  • HS is characterized by large cells, often misdiagnosed.
  • Immunohistochemistry is crucial, showing markers like CD163 and CD68.
  • High PD-L1 expression suggests a therapeutic target; common mutations include RAS/MAPK, PI3K/AKT/mTOR, CDKN2A, and TP53.

Conclusions:

  • Management of HS lacks a standard protocol, with surgery and radiotherapy for localized disease.
  • Systemic treatment options for disseminated HS are limited.
  • Further research into targeted therapies based on genetic alterations and PD-L1 expression is warranted.